Andreas Kjær

Andreas Kjær

Professor


  1. 2022
  2. Published

    Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

    Wolsk, E., Jürgens, M., Schou, Morten, Ersbøll, M., Hasbak, P., Kjær, Andreas, Zerahn, B., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Kistorp, Caroline Michaela Nervil & Gustafsson, Finn, 2022, In: Diabetes. 71, 4, p. 812-820 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

    Loft, Mathias Hougaard, Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Otorai, P., Knigge, Ulrich & Kjær, Andreas, 2022, In: Journal of Neuroendocrinology. 34, S1, p. 151-151 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Published
  5. Published

    Sex differences and caffeine impact in adenosine-induced hyperemia

    Lassen, M. L., Byrne, C., Sheykhzade, Majid, Wissenberg, M., Hurry, P. K., Schmedes, A. V., Kjær, Andreas & Hasbak, P., 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 3, p. 431-437 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms

    Holmager, P., Langer, Seppo W., Kjær, Andreas, Ringholm, L., Garbyal, Rajendra Singh, Pommergaard, Hans-Christian L, Hansen, C. P., Federspiel, B., Andreassen, Mikkel & Knigge, Ulrich, 2022, In: Current Treatment Options in Oncology. 23, 6, p. 806-817 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

    Toner, Y. C., Ghotbi, A. A., Naidu, S., Sakurai, K., van Leent, M. M. T., Jordan, S., Ordikhani, F., Amadori, L., Sofias, A. M., Fisher, E. L., Maier, A., Sullivan, N., Munitz, J., Senders, M. L., Mason, C., Reiner, T., Soultanidis, G., Tarkin, J. M., Rudd, J. H. F., Giannarelli, C. & 6 others, Ochando, J., Pérez-Medina, C., Kjær, Andreas, Mulder, W. J. M., Fayad, Z. A. & Calcagno, C., 2022, In: Scientific Reports. 12, 1, 15 p., 6185.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journalLetterResearchpeer-review

  9. Published

    Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients

    Risør, L. M., Binderup, Tina, Fosbøl, Marie Øbro, Loft, A., Friborg, Jeppe Tang & Kjær, Andreas, 2022, In: Scientific Reports. 12, 1, 11 p., 19126.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. 2021
  11. Published

    Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Zobel, E. H., Wretlind, A., Ripa, Rasmus Sejersten, Rotbain Curovic, V., von Scholten, B. J., Suvitaival, T., Hansen, T. W., Kjær, Andreas, Legido-Quigley, C. & Rossing, Peter, Sep 2021, In: BMJ open diabetes research & care. 9, 1, p. 1-9 e002395.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture in brain tumors

    Kostrikov, S., Johnsen, K. B., Braunstein, T. H., Gudbergsson, J. M., Fliedner, F. P., Obara, E. A. A., Hamerlik, P., Hansen, A. E., Kjær, Andreas, Hempel, C. & Andresen, T. L., Jul 2021, In: Communications Biology . 4, 1, 16 p., 815.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...6 7 8 9 10 11 12 13 ...70 Next

ID: 13402